130 related articles for article (PubMed ID: 10381034)
1. Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats.
Bendele A; Sennello G; McAbee T; Frazier J; Chlipala E; Rich B
J Rheumatol; 1999 Jun; 26(6):1225-9. PubMed ID: 10381034
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
3. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
Bendele AM; Chlipala ES; Scherrer J; Frazier J; Sennello G; Rich WJ; Edwards CK
Arthritis Rheum; 2000 Dec; 43(12):2648-59. PubMed ID: 11145022
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Dec; 52(12):3755-60. PubMed ID: 16320326
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
6. Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats.
Bendele AM; McComb J; Gould T; Frazier J; Chlipala E; Seely J; Kieft G; Edwards CK
Clin Exp Rheumatol; 1999; 17(5):553-60. PubMed ID: 10544838
[TBL] [Abstract][Full Text] [Related]
7. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats.
Bendele AM; McComb J; Gould T; Frazier J; Chlipala ES; Seely J; Kieft G; Wolf J; Edwards CK
Inflamm Res; 1999 Aug; 48(8):453-60. PubMed ID: 10493163
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Rovensky J; Svík K; Stancíková M; Istok R
J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
10. Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy.
McComb J; Gould T; Chlipala E; Sennelo G; Frazier J; Kieft G; Seely J; Edwards CK; Bendele A
J Rheumatol; 1999 Jun; 26(6):1347-51. PubMed ID: 10381054
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
12. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
13. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of combined methotrexate/chloroquine therapy in adjuvant-induced arthritis.
Silva MA; Ishii-Iwamoto EL; Bracht A; Caparroz-Assef SM; Kimura E; Cuman RK; Bersani-Amado CA
Fundam Clin Pharmacol; 2005 Aug; 19(4):479-89. PubMed ID: 16011736
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium.
Rovenský J; Svík K; Matha V; Istok R; Kamarád V; Ebringer L; Ferencík M; Stancíková M
Ann N Y Acad Sci; 2005 Jun; 1051():570-81. PubMed ID: 16126997
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
17. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
18. Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis.
Morgan SL; Chen DT; Carlee J; Baggott JE
J Rheumatol; 2004 Sep; 31(9):1693-7. PubMed ID: 15338486
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate treatment suppresses local cytokine and chemokine production in rat adjuvant arthritis.
Barsig J; Yam G; Lehner MD; Beume R
Drugs Exp Clin Res; 2005; 31(1):7-11. PubMed ID: 15921024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
